Jänne PA - Search Results

1

The role of epidermal growth factor receptor in advanced non-small cell lung carcinoma.

Jänne PA. Jänne PA. Ann Med. 2003;35(7):450-7. doi: 10.1080/07853890310010889. Ann Med. 2003. PMID: 14649327 Free article. Review.

2

Lung cancer presenting with solitary bone metastases. Case 2: acrometastasis as an initial presentation of non-small-cell lung carcinoma.

Jänne PA, Datta MW, Johnson BE. Jänne PA, et al. J Clin Oncol. 1999 Sep;17(9):2998-3001. doi: 10.1200/JCO.1999.17.9.2998. J Clin Oncol. 1999. PMID: 10561378 No abstract available.

3

Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy.

Jänne PA, Rodriguez-Thompson D, Metcalf DR, Swanson SJ, Greisman HA, Wilkins-Haug L, Johnson BE. Jänne PA, et al. Oncology. 2001;61(3):175-83. doi: 10.1159/000055371. Oncology. 2001. PMID: 11574771 Review.

4

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.

Jänne PA, Taffaro ML, Salgia R, Johnson BE. Jänne PA, et al. Cancer Res. 2002 Sep 15;62(18):5242-7. Cancer Res. 2002. PMID: 12234991

5

Chemotherapy for malignant pleural mesothelioma.

Janne PA. Janne PA. Clin Lung Cancer. 2003 Sep;5(2):98-106. doi: 10.3816/CLC.2003.n.023. Clin Lung Cancer. 2003. PMID: 14596692 Review.

6

Concurrent docetaxel and thoracic radiation in non-small-cell lung cancer.

Jänne PA, Skarin AT. Jänne PA, et al. Clin Lung Cancer. 2002 May;3 Suppl 2:S37-41. doi: 10.3816/clc.2002.s.012. Clin Lung Cancer. 2002. PMID: 14720346

7

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study.

Jänne PA, Gurubhagavatula S, Yeap BY, Lucca J, Ostler P, Skarin AT, Fidias P, Lynch TJ, Johnson BE. Jänne PA, et al. Lung Cancer. 2004 May;44(2):221-30. doi: 10.1016/j.lungcan.2003.12.014. Lung Cancer. 2004. PMID: 15084387 Clinical Trial.

8

Basic treatment considerations using chemotherapy for patients with small cell lung cancer.

Johnson BE, Jänne PA. Johnson BE, et al. Among authors: janne pa. Hematol Oncol Clin North Am. 2004 Apr;18(2):309-22. doi: 10.1016/j.hoc.2003.12.008. Hematol Oncol Clin North Am. 2004. PMID: 15094173 Review. No abstract available.

9

Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.

Tracy S, Mukohara T, Hansen M, Meyerson M, Johnson BE, Jänne PA. Tracy S, et al. Among authors: janne pa. Cancer Res. 2004 Oct 15;64(20):7241-4. doi: 10.1158/0008-5472.CAN-04-1905. Cancer Res. 2004. PMID: 15492241

10

Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: case 4. Mutation of the epidermal growth factor receptor in an elderly man with advanced, gefitinib-responsive, non-small-cell lung cancer.

Cho D, Kocher O, Lee JC, Tenen DG, Meyerson ML, Janne PA, Halmos B. Cho D, et al. Among authors: janne pa. J Clin Oncol. 2005 Jan 1;23(1):235-7. doi: 10.1200/JCO.2005.07.169. J Clin Oncol. 2005. PMID: 15625379 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

486 results

Search Page

Filters